Health News
Brain Salt Level May Indicate MS Stage
Predicting the course of multiple sclerosis (MS) is difficult. New patients are often confused about what to expect from their condition. The good news is you may be able to predict the stage of the disease based on levels of sodium found on the brain.
Relax to Prevent MS Progression
Headaches, muscle tension, pain, fatigue and anxiety are all signs that stress is working over your body. We know that managing our stress levels is important, but for multiple sclerosis (MS) patients, it may be key to halting the disease’s progression.
Botox Considered as MS Tremor Treatment
Tremors in the upper limbs are a major concern for two-thirds of multiple sclerosis (MS) patients as they can contribute to disability and are considered by to be one of the most difficult symptoms to treat.
TV Star Jack Osbourne Has Multiple Sclerosis
Jack Osbourne , the 26-year old reality TV star whose teenage antics on The Osbournes jump-started his acting career, has been diagnosed with multiple sclerosis.
Cannabis: An Infamous Treatment
Multiple sclerosis (MS) can be both painful, crippling and difficult to treat. But medical marijuana may provide some relief.
Pregnancy and Multiple Sclerosis: Are Drugs Safe?
Living with a chronic disease can be difficult. Multiple sclerosis (MS), an autoimmune disease that affects the brain and spinal cord, is a condition that’s becoming easier to treat because of advances in medicine. Still, many women worry that the disease could prevent them from having children.
MS occurs when the body’s immune system eats away at the protective sheath, called myelin, that covers nerves, which results in irreversible deterioration of the nerves. The condition is more common among women, especially women between the ages of 20 and 40 – during childbearing age.
...
MS Patients Should Evaluate Unproven Treatments
The U.S. Food and Drug Administration (FDA) is warning of possible risks associated with liberation therapy, an unproven multiple sclerosis (MS) treatment.
Cardiovascular Monitoring With Gilenya
The U.S. Food and Drug Administration (FDA) has completed its evaluation of a report of a patient who died after the first dose of multiple sclerosis drug Gilenya ( fingolimod ).
Potential Dangers of Multiple Sclerosis Treatment
The U.S. Food and Drug Administration is alerting health care professionals and patients about injuries and death associated with the use of an experimental procedure sometimes called “liberation therapy” or the “liberation procedure” to treat chronic cerebrospinal venous insufficiency ( CCSVI ).
Fish Oil Disappoints as MS Therapy
Multiple sclerosis is a chronic central nervous system disease with no cure, only treatments. Researchers have fervently worked to come up with new therapies to treat the condition.